Cargando…

A Study of Vitiligo in Type 2 Diabetic Patients

CONTEXT: Diabetes mellitus is associated with many skin manifestations including vitiligo. Vitiligo occurs more commonly in Type 1 diabetes mellitus. A few recent studies have shown its increased occurrence in Type 2 diabetes mellitus. AIMS: This study aims to study the prevalence of vitiligo in Typ...

Descripción completa

Detalles Bibliográficos
Autores principales: Raveendra, Leena, Hemavathi, Rekha N, Rajgopal, Sushma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363140/
https://www.ncbi.nlm.nih.gov/pubmed/28400636
http://dx.doi.org/10.4103/ijd.IJD_360_16
_version_ 1782517115893317632
author Raveendra, Leena
Hemavathi, Rekha N
Rajgopal, Sushma
author_facet Raveendra, Leena
Hemavathi, Rekha N
Rajgopal, Sushma
author_sort Raveendra, Leena
collection PubMed
description CONTEXT: Diabetes mellitus is associated with many skin manifestations including vitiligo. Vitiligo occurs more commonly in Type 1 diabetes mellitus. A few recent studies have shown its increased occurrence in Type 2 diabetes mellitus. AIMS: This study aims to study the prevalence of vitiligo in Type 2 diabetic patients and to compare the prevalence of vitiligo in age- and sex-matched group of nondiabetic population. SETTINGS AND DESIGN: The present study was a hospital-based cross-sectional study conducted in the Department of Dermatology in a tertiary care hospital. SUBJECTS AND METHODS: Six hundred consecutive consenting patients of Type 2 diabetes were included in the study group and age- and sex-matched controls were healthy nondiabetic adult volunteers attending the Department of Dermatology. Fasting and postprandial blood sugar levels were done. A complete history, physical examination, and wood's lamp examination to detect vitiligo were conducted. In all those with vitiligo, the type of vitiligo was noted. STATISTICAL ANALYSIS USED: Data were analyzed using SPSS software version 20.0. Comparison between the presence of vitiligo in cases and controls was done using Chi-square test with P = 0.05 for significance. RESULTS: Vitiligo was seen in 12% of cases and 6% of control group which was statistically significant (P < 0.01). There was no significant difference between cases and controls with respect to type of vitiligo. CONCLUSIONS: Vitiligo can occur in Type 2 diabetics as seen in our study and few other recent studies. The exact pathogenesis is not very clear and needs further consideration.
format Online
Article
Text
id pubmed-5363140
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-53631402017-04-11 A Study of Vitiligo in Type 2 Diabetic Patients Raveendra, Leena Hemavathi, Rekha N Rajgopal, Sushma Indian J Dermatol Original Article CONTEXT: Diabetes mellitus is associated with many skin manifestations including vitiligo. Vitiligo occurs more commonly in Type 1 diabetes mellitus. A few recent studies have shown its increased occurrence in Type 2 diabetes mellitus. AIMS: This study aims to study the prevalence of vitiligo in Type 2 diabetic patients and to compare the prevalence of vitiligo in age- and sex-matched group of nondiabetic population. SETTINGS AND DESIGN: The present study was a hospital-based cross-sectional study conducted in the Department of Dermatology in a tertiary care hospital. SUBJECTS AND METHODS: Six hundred consecutive consenting patients of Type 2 diabetes were included in the study group and age- and sex-matched controls were healthy nondiabetic adult volunteers attending the Department of Dermatology. Fasting and postprandial blood sugar levels were done. A complete history, physical examination, and wood's lamp examination to detect vitiligo were conducted. In all those with vitiligo, the type of vitiligo was noted. STATISTICAL ANALYSIS USED: Data were analyzed using SPSS software version 20.0. Comparison between the presence of vitiligo in cases and controls was done using Chi-square test with P = 0.05 for significance. RESULTS: Vitiligo was seen in 12% of cases and 6% of control group which was statistically significant (P < 0.01). There was no significant difference between cases and controls with respect to type of vitiligo. CONCLUSIONS: Vitiligo can occur in Type 2 diabetics as seen in our study and few other recent studies. The exact pathogenesis is not very clear and needs further consideration. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5363140/ /pubmed/28400636 http://dx.doi.org/10.4103/ijd.IJD_360_16 Text en Copyright: © 2017 Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Raveendra, Leena
Hemavathi, Rekha N
Rajgopal, Sushma
A Study of Vitiligo in Type 2 Diabetic Patients
title A Study of Vitiligo in Type 2 Diabetic Patients
title_full A Study of Vitiligo in Type 2 Diabetic Patients
title_fullStr A Study of Vitiligo in Type 2 Diabetic Patients
title_full_unstemmed A Study of Vitiligo in Type 2 Diabetic Patients
title_short A Study of Vitiligo in Type 2 Diabetic Patients
title_sort study of vitiligo in type 2 diabetic patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363140/
https://www.ncbi.nlm.nih.gov/pubmed/28400636
http://dx.doi.org/10.4103/ijd.IJD_360_16
work_keys_str_mv AT raveendraleena astudyofvitiligointype2diabeticpatients
AT hemavathirekhan astudyofvitiligointype2diabeticpatients
AT rajgopalsushma astudyofvitiligointype2diabeticpatients
AT raveendraleena studyofvitiligointype2diabeticpatients
AT hemavathirekhan studyofvitiligointype2diabeticpatients
AT rajgopalsushma studyofvitiligointype2diabeticpatients